This webinar took place on September 30th 2020
Register to download slides & media
Sergey Arzhantsev, Ph.D
Research Physicist at FDA
Sergey Arzhantsev is Research Physicist in the Office of Testing and Research at the Food and Drug Administration in St. Louis, MO. He joined the Food and Drug Administration in 2009 and maintains an active research program in state-of-the-art technologies for drug analysis to support quality assessments. He received Ph.D. in Physics from M. V. Lomonosov Moscow State University in Moscow, Russia. He subsequently performed research at the Institute for Molecular Science, Japan and the Pennsylvania State University. In his present position at the FDA, Dr. Arzhantsev utilizes spectroscopic methods to study the quality and stability of pharmaceutical and biotechnology products.
Adrian Davis, Ph.D
Data Integrity Lead; Pfizer
Adrian Davis is a team leader and Research Fellow in Analytical R&D at Pfizer’s research laboratories in Sandwich, UK. He has over 25 yrs. of R&D experience, and in recent years has led Data integrity activities for Pfizer’s Pharmaceutical Sciences organization, focusing on the laboratory operations supporting clinical manufacturing activities. He’s also part of a strategic leadership group that is implementing Digital Transformation within the R&D environment and is very interested in technologies that help to simplify a very diverse laboratory data landscape. Fun fact: Adrian’s first professional lecture was at a Bruker NMR user meeting in the early 1990s, and he still remembers being so nervous that he couldn’t eat any of the lavish lunch that was provided!